PRODUCTS

WHERE SCIENCE TURNS INTO PRODUCTS

FROM THE ACTIVE PHARMACEUTICAL INGREDIENT (API) TO THE FINISHED DOSAGE FORM (FDF) AMEGA Biotech has a complete portfolio of first generation biogenerics and a wide range of second-generation molecules.


BIOTECHNOLOGICAL MEDICINES

OUR LATEST DEVELOPMENTS

AMEGA Biotech is committed to continuous improvement and growth. Development of new technological platforms to contribute to the growth of biotechnolgy for human pharmaceuticals is a key objective in our project. Latest developments include construction of a production site for high molecular weight proteins with three service units: Multipurpose Pilot Plant, biopharmaceutical quality control lab, and Cell Banks viral control lab. Also, a Nano technology project involves the creation of an innovative platform for development and production of smart nano carriers for injectable pharmaceuticals.